Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of 24-valent Pneumococcal Conjugate Vaccine in Infants and Young Children
CTR20254598Phase 2Active
- Sponsor
- Sino Biopharmaceutical Limited
- Start
- Nov 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Sinovac PCV24 in pneumococcal disease, sponsored by Sino Biopharmaceutical Limited. Started Nov 2025; status: active.
02
Drugs
Sinovac PCV24
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on CTR20254598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254598.